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Abstract
Background: Astragalus polysaccharide (APS) has been used as an immunomodulator that can enhance immune responses,
whereas the immunomodulatory effects of APS on porcine peripheral blood mononuclear cells (PBMCs) exposed to porcine
reproductive and respiratory syndrome virus (PRRSV) and classical swine fever virus (CSFV) have not been investigated.
Methodology/Principal Findings: Porcine PBMCs were cultured in complete RPMI media in the presence of the R98-strain
of PRRSV (5610
4 TCID50/ml) or C-strain of CSFV (10
3 TCID50/ml) with or without APS. The expression of mRNA for CD28,
cytotoxic T-lymphocyte antigen 4 (CTLA-4), transforming growth factor-b (TGF-b), interleukin 2 (IL-2) and IL-10 was assayed
by TaqMan real-time RT-PCR. The expression of mRNA for CD28 and CTLA-4 increased at 24 h after stimulation of PBMCs
with CSFV and the increased production of CTLA-4 was confirmed by western blot analysis, whereas the increases were
inhibited by the addition of APS. In addition, APS alone upregulated IL-2 and TGF-b mRNA expression in PBMCs and the
addition of APS had the capacity to prevent a further increase in IL-2 mRNA expression in PBMCs during CSFV or PRRSV
infection, but had no effect on TGF-b mRNA expression. The production of tumor necrosis factor-alpha (TNF-a) increased at
12 h after stimulation with PRRSV or CSFV, but not with PRRSV plus APS or CSFV plus APS, whereas the addition of APS to
PBMCs infected with PRRSV or CSFV promoted IL-10 mRNA expression.
Conclusions: We suggested that APS had immunomodulatory effects on cells exposed to PRRSV or CSFV. It might be that
APS via different mechanisms affects the activities of immune cells during either PRRSV or CSFV infection. This possibility
warrants further studies to evaluate whether APS would be an effective adjuvant in vaccines against PRRSV or CSFV.
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Introduction
Porcine reproductive and respiratory syndrome virus
(PRRSV) and classical swine fever virus (CSFV) are both
single-stranded RNA viruses that cause highly contagious
diseases and lead to tremendous economic losses worldwide
[1,2]. Invasion of PRRSV begins with the inability of the host’s
anti-viral defenses to control replication of the virus, which arises
from evasion of the early warning components of the immune
system and leads to long-lasting viremia [3,4]. Infection with
CSFV causes severe leukopenia, particularly of the lymphocytes.
The target cells for CSFV in the peripheral blood appear to be
mainly monocytes, lymphocytes and granulocytic cells, but all
leukocyte populations can be depleted during CSFV infection
[5]. Viral infectious diseases are not treated effectively with drugs
but are prevented by vaccination with appropriate vaccines.
Combined application of a vaccine with an adjuvant or
immunopotentiator could improve the efficacy of a vaccine;
however, new strains of virus resistant to chemical adjuvants
continue to emerge and potent adjuvant action is often
correlated with increased toxicity [6].
Astragalus membranaceus (AM) is a traditional Chinese medicinal
herb used as a tonic to enhance immune defense functions. The
antiviral activity of AM is thought to be mainly due to modulatory
effects on the immune system. Evidence indicates that AM extract
has mitogenic activity on mammalian splenocytes, and is capable
of enhancing lymphocyte blastogenesis and stimulating macro-
phage activation without cytotoxic effects [7,8]. Astragalus
polysaccharide (APS), extracted from AM, has an extensive effect
on alleviating immune stress [9], activating the immune system by
clearing the immune complex [10], enhancing the transformation
of T lymphocytes, and activating B lymphocytes and dendritic cells
(DC) [11–13]. Several hundred cellular genes have been shown to
be altered by AM extract (e.g., Astragalus) treatment. Some of these
responses are associated with the induction of a cytokine gene
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inflammatory response such as promoting the production of
interleukin 2 (IL-2) and interferon-gamma (IFN-c), and thus
improving immune defense functions and resisting the invasion of
the external pathogens [14–17].
Peripheral blood mononuclear cells (PBMCs) are a heteroge-
nous population of blood cells that include monocyte and
lymphocyte immune cells consisting of T-cells, B cells and NK
cells. These blood cells represent a critical component in the
immune system for fighting infection and adapting to intruders.
Since the development of ex vivo production of immune cells,
PBMCs have emerged as a critical resource for immune responses
to PRRSV [18], and CSFV infection is demonstrated to strongly
affect the function of PBMCs [19].
CD28 may be considered one of the most important co-
stimulatory receptors necessary for T-cell activation [20]. CD28 is
constitutively expressed on both naı ¨ve and activated T-cells and
lowers the T-cell receptor (TCR) activation threshold by binding
cognate ligands B7-1/CD80 or B7-2/CD86 on the surface of
professional antigen presenting cells (APCs) [21]. Studies exam-
ining primary infections with other RNA viruses such as vesicular
stomatitis virus and influenza type A virus indicated that CD28
was required for primary expansion of antiviral CD8
+ T-cells
[22,23].
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a structural
homolog of the co-stimulatory molecule CD28 and is a negative
regulator required for T-cell homeostasis and tolerance [24].
CTLA-4 is about 30% homologous with CD28 and binds to the
same ligands as CD28, albeit with a much higher affinity, and
CD28 was shown to be important in enhancement of viability and
cytokine production by T-cells [25]. This suggests that CTLA-4
preferentially interacts with homologous ligands, and therefore
aids in the termination of immune responses activated by CD28
[26]. CD28 and CTLA-4 transduce activation signals that lead to
the expression of anti-apoptotic proteins and enhance the synthesis
of several cytokines including IL-2 [27].
The tumor necrosis factor (TNF) superfamily is a second group
of co-stimulatory molecules. Previous studies have suggested that
TNF family members can replace CD28 co-stimulation in primary
antiviral CD8
+ T-cell responses [28,29]. Cytokines, such as the
proinflammatory cytokines TNF-a, IL-2 and IFN-c and the anti-
inflammatory cytokines transforming growth factor-b (TGF-b) and
IL-10 are detected during the course of inflammation.
Therefore, the purpose of the present study was to investigate
CD28, CTLA-4 and some cytokines involved in immune
responses of porcine PBMCs exposed to PRRSV and CSFV with
or without APS. These data may help evaluate whether APS could
be served as an adjuvant in vaccines against PRRSV or CSFV.
Results
PBMC proliferation
There were no significant differences in PBMC proliferation
among the different stimulation conditions at either 24 h or 48 h
after stimulation. At 72 h after stimulation, PBMC proliferation
was higher in the presence of PRRSV or CSFV only compared to
PRRSV plus APS (P=0.006) or CSFV plus APS (P=0.005),
respectively (Figure 1).
Expression of CD28 and CTLA-4
Compared to medium alone, CD28 mRNA expression
increased significantly at 24 h after stimulation with CSFV
(P,0.001) but not with CSFV plus APS (Figure 2A); in contrast,
CD28 mRNA expression decreased (P,0.001) at both 24 h and
48 h after stimulation with only APS. Notably, CD28 mRNA
expression was higher (P,0.001) in the presence of PRRSV alone
than in the presence of PRRSV plus APS at 24 h after stimulation.
At 48 h after stimulation, the expression of CD28 increased
(P,0.001) in the presence of PRRSV, but decreased (P,0.001) in
the presence of CSFV compared to medium alone.
Similarly, CTLA-4 mRNA expression increased significantly at
24 h after stimulation with CSFV (P,0.045) but not with CSFV
Figure 1. The cell proliferation determined by MTT assay. Porcine PBMCs were cultured with medium alone, APS, PRRSV, PRRSV plus APS,
CSFV, or CSFV plus APS. Cell proliferation was assessed after 24, 48 and 72 h of cultivation. The results are presented as a percentage relative to the
OD570 values of nonstimulated PBMC (100%) at the same day. Data are presented as means 6 SEM of three independent experiments. Within the
same time: *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0029320.g001
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stimulation, the expression of CTLA-4 mRNA was higher
(P,0.001) in the presence of PRRSV alone than in the presence
of PRRSV plus APS, but lower (P=0.003) in the presence of
CSFV alone than in the presence of CSFV plus APS.
Furthermore, western blot analysis indicated that the production
of CTLA-4 increased at 24 h after stimulation with CSFV
compared to medium alone (Figure 3).
Expression of IL-2, TGF-b and IL-10
An increase in IL-2 mRNA expression (P,0.001) was detected
in the presence of APS only compared to medium alone
(Figure 2C). IL-2 mRNA expression increased significantly
(P,0.001) at 48 h after stimulation with PRRSV or CSFV, but
not with PRRSV plus APS or CSFV plus APS compared to
medium alone. The expression of TGF-b mRNA increased
(P=0.004) at 24 h after stimulation with APS, but neither with
PRRSV nor CSFV with or without APS compared to medium
alone (Figure 2D). At 48 h after stimulation, there were no
significant differences in TGF-b mRNA expression among the
different stimulation conditions.
IL-10 mRNA expression increased significantly at 24 h
(P,0.001) and 48 h (P,0.001) after stimulation with PRRSV
plus APS or CSFV plus APS, but not with PRRSV or CSFV only
compared to medium alone (Figure 2E).
Production of TNF-a and IFN-c
The production of TNF-a increased significantly at 12 h after
stimulation with PRRSV (P,0.001) or CSFV (P=0.030), but not
with PRRSV plus APS or CSFV plus APS compared to medium
alone (Figure 4). At 24 h after stimulation, the production of TNF-
a was even higher in the presence of PRRSV (P,0.001) or CSFV
(P=0.013) than in the presence of PRRSV plus APS or CSFV plus
APS, respectively. Notably, the addition of APS did not
significantly increase the production of TNF-a in comparison to
medium alone throughout the study.
IFN-c production in culture supernatants was not detected by
ELISA assay.
Discussion
Effective T-cell responses are crucial for the clearance of viral
infections. In some instances, however, the immune response is
unable to control viral replication, thereby allowing the virus to
persist. The activation and expansion of naı ¨ve T-cells requires co-
Figure 2. Relative mRNA expression of CD28 (A), CTLA-4 (B), IL-2 (C), TGF-b (D) and IL-10 (E) in porcine PBMCs. Relative mRNA
expression in porcine PBMCs cultured with medium alone, APS, PRRSV, PRRSV plus APS, CSFV, or CSFV plus APS. Gene expression was analysed
by Taqman real-time RT-PCR. Data are presented as means 6 SEM of three independent experiments. Within the same time: *, P,0.05; **, P,0.01;
***, P,0.001.
doi:10.1371/journal.pone.0029320.g002
Figure 3. Western blot of CTLA-4 expression in porcine PBMC
stimulated with CSFV. Proteins from cell lysate were separated
by SDS-PAGE gel and transferred to a nitrocellulose membrane. The
membrane was probed with human CTLA-4 affinity purified polyclonal
antibody and rabbit anti-goat IgG HRP affinity purified antibody. The
GAPDH in each sample was amplified as an internal control as shown
in the lower panel. Data are representative of three independent
experiments.
doi:10.1371/journal.pone.0029320.g003
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affect the optimal development of secondary responses, prolifer-
ation of memory CD4
+ and CD8
+ T-cells and clearance of viral
infections [30,31]. CTLA-4 is a T-cell co-stimulator, which is
structurally related to CD28 and exhibits inhibitory activity
toward T-cell activation [32,33]. It has been reported that APS
has a dramatic effect on immunologic enhancement and antiviral
action such as promoting the expression of CD86, one of the
ligands for CD28 and CTLA-4 [34]. We found that the expression
of CD28 and CTLA-4 was increased by exposure of cells to CSFV
and the increased production of CTLA-4 was confirmed by
western blot analysis, whereas the increases were inhibited by the
addition of APS. In addition, the addition of APS also decreased
CD28 and CTLA-4 mRNA expression in porcine PBMCs infected
with PRRSV. Our findings indicated that APS downregulated the
expression of CD28 and CTLA-4 in porcine PBMCs infected with
CSFV or PRRSV.
IL-2 is a potent T-cell growth factor that induces lymphokine-
activated killer activity, mediates activation-induced cell death and
is an essential factor for the development of regulatory T-cells
(Tregs) [35]. Data presented here unequivocally showed that APS
alone increased IL-2 mRNA expression in PBMCs and the
addition of APS had the capacity to prevent a further increase in
IL-2 mRNA expression in PBMCs during CSFV or PRRSV
infection. A previous study indicated that IL-2 did not have the
capacity to prevent apoptosis of T-cells from pigs infected with
CSFV when tested in vitro; in contrast, it sometimes enhanced cell
death [5]. Therefore, a possible concept for lymphocyte depletion
during CSFV infection might be an aberrant triggering of
lymphocytes by an imbalance of virus-induced immune factors
or by a viral superantigen.
Tregs can suppress immune responses through the production
of immunosuppressive cytokines such as TGF-b and IL-10 [36].
Anti-inflammatory cytokines such as TGF-b and IL-10 specifically
inhibit the release of TNF and other proinflammatory mediators
[37]. We found that APS had no effect on TGF-b mRNA
expression, but increased IL-10 mRNA expression in PBMCs
infected with PRRSV or CSFV. It may be a multistep process in
which increased IL-10 initially induces the suppressive environ-
ment that may prevent the induction of IL-2 and TNF-a.
Interleukin-10 is identified as one of the postulate mechanisms for
immunomodulation, both systemically and locally, during an early
stage of PRRSV infection [38,39]. Recent data suggest that the
prevalence of IL-10 responses to PRRSV was higher in vaccinated
animals than in naı ¨ve pigs [40]. On the other hand, the increased
IL-10 production during persistent viral infection induces T-cell
inactivation and results in the prevention of viral clearance
[41,42].
The synthesis and release of proinflammatory cytokines often
represent changes in immune responses during the course of CSF,
and TNF-a may be one of the most important proinflammatory
mediators in the pathogenesis of the disease. An infection of
monocytes by CSFV could induce TNF-a secretion [43]. We
showed that primed porcine PBMCs could produce TNF-a in
response to PRRSV or CSFV. Notably, TNF-a production was
higher in PBMCs infected by PRRSV than by CSFV. It has been
shown that TNF-a exerts a strong inhibitory effect on the
transcription of the CD28 gene [44]. This may be an explanation
for the increased CD28 mRNA expression in PBMCs exposed to
CSFV, but not in PBMCs exposed to PRRSV.
IFN-c has been thought to play a crucial role against infectious
viruses. There is a positive correlation between IFN-c responses
Figure 4. Enzyme-linked immunosorbent assay of TNF-a in cell culture supernatants. Porcine PBMCs were cultured with medium alone,
APS, PRRSV, PRRSV plus APS, CSFV, or CSFV plus APS. Data are presented as means 6 SEM of three independent experiments. Within the same time:
*, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0029320.g004
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PRRSV and the addition of IFN-c inhibited PRRSV replication
in macrophages [45]. Previous studies have shown that PRRSV
infection failed to elicit any significant inflammatory cytokine
expression as an initial response [46,47]. The production of IFN-c
in supernatant was not detected in our study. Although the
significance of a relatively low IFN-c response during PRRSV
infection relating to protective immunity is unknown, this may
allow for the establishment of persistent infection of PRRSV in
pigs.
In conclusion, the present data indicated that APS alone
upregulated IL-2 and TGF-b mRNA expression in PBMCs. The
addition of APS to PBMCs infected with PRRSV or CSFV had no
effect on TGF-b mRNA expression, downregulated the expression
of mRNA for CD28, CTLA-4 and IL-2, but promoted IL-10
mRNA expression. Thus, we suggested that APS had immuno-
modulatory effects on cells exposed to PRRSV or CSFV. It might
be that APS via different mechanisms affects the activities of
immune cells during either PRRSV or CSFV infection. This
possibility warrants further studies to evaluate whether APS would
be an effective adjuvant in vaccines against PRRSV or CSFV.
Materials and Methods
Virus and Astragalus polysaccharides
The R98-strain of PRRSV and the rabbit propagated C-strain
of CSFV were kindly provided by Dr. Baoshou Yang (Ruipu
Company, Hebei, China). Freeze-dried APS was kindly provided
by Prof. Fenghua Liu (Beijing University of Agriculture, Beijing,
China).
Animals and blood sampling
Six twelve-week-old crossbred pigs, free of PRRSV- and CSFV-
specific antibodies and antigens, were obtained from a commercial
farm. The use and care of all animals in this study was approved
by the China Agricultural University Animal Ethics Committee
under the protocol (CAU-AEC-2010-038). Blood was collected
from the anterior vena cava and anti-coagulated with 0.1 volume
of 26acid–citrate–dextrose (0.15 M sodium citrate, 0.076 M citric
acid monohydrate, 0.287 M dextrose) solution.
PBMC isolation
PBMCs were prepared by Ficoll gradient centrifugation
according to the manufacturer’s instructions. Briefly, 10 ml of
Ficoll–Hypaque (Sigma, St. Louis, MO) was stratified under 20 ml
of peripheral blood and centrifugation was performed at 400 6g
for 20 min at room temperature. Recovered PBMCs were washed
three times with D-PBS (2.67 mM KCl, 1.47 mM KH2PO4,
137.93 mM NaCl, 8.06 mM Na2HPO4?7H2O). The number of
living cells was counted by trypan blue (Sigma, St. Louis, MO)
staining at a concentration of 0.4 mg/ml under the microscope.
For all of the following experiments, freshly isolated PBMC were
used.
Cell cultures
Cells were cultured in RPMI-1640 culture medium (Invitrogen,
Carlsbad, CA) containing 2 mM L-glutamine enriched with
100 U/ml penicillin/streptomycin (Sigma, St. Louis, MO) and
10% heat-inactivated fetal calf serum and were counted to
determine the PBMC cell number with an equal volume of trypan
blue under the microscope. The cell concentration was brought to
2610
6 cells/ml culture medium in the presence of PRRSV (5610
4
TCID50/ml), CSFV (10
3 TCID50/ml) or APS (10 mg/ml). Cells in
the virus groups (PRRSV or CSFV) were allocated to the non-APS
and APS (10 mg/ml) groups. Cells and supernatants were
harvested at 0, 12, 24, 48 and 72 h after stimulation and stored
at 280uC until further analysis.
MTT assay
Cells were cultured at 2610
6 cells/well and cell proliferation
was measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide) (Sigma, St. Louis, MO) colorimetric assay at
24, 48 and 72 h after stimulation. Ten ml of MTT filtered stock
solution (5 mg/ml) was added to 200 ml of cells and incubated for
4 h at 37uC. After incubation, 100 ml 0.1 M HCl in absolute
isopropanol was added to each tube. The optical density (OD) at a
wavelength of 570 nm was measured using an enzyme-linked
immunosorbent assay plate reader (Bio-Rad, Hercules, CA).
Results are presented as % over nonstimulated PBMC (100%) at
the same day.
Total RNA extraction
Total RNA was extracted from PBMC using Trizol reagent
(Invitrogen, Carlsbad, CA). The final RNA was eluted in an
appropriate amount of RNase-free water (Qiagen, Valencia, CA).
For each sample, the integrity of RNA extracted was analyzed by
agarose gel electrophoresis by staining with ethidium bromide and
visualization under UV light. The amount of RNA extracted was
determined and its purity (OD260/OD280 absorption ratio .1.9)
was verified using a NanoDropH ND-2000C Spectrophotometer
(NanoDrop Technologies Inc., Wilmington, DE).
Quantitative real-time RT-PCR
Quantitative real-time RT-PCR was performed using a 7500
Real-Time PCR System (Applied Biosystems, Foster City, CA).
For each sample, 600 ng of total RNA were added directly to a
TaqMan one-step RT-PCR reaction containing rTth DNA
polymerase enzyme (Applied Biosystems, Foster City, CA). The
thermal cycling profile of this assay consisted of a 25 min reverse
transcription step that was performed at 42uC for 5 min, then
60uC for 20 min, 2 min of Taq polymerase activation at 95uC,
followed by 45 cycles of PCR at 95uC of denaturing for 15 s and
60uC of annealing/extension for 1 min. A non-template control of
nuclease-free water was included in each run. All reactions were
conducted in triplicate.
IL-10, TGF-b and hypoxanthine phosphoribosyl-transferase
(HPRT) were assayed using published sequences of primers and
probes [48], which are listed in Table 1. Probes were dual-labeled
with 6-carboxyfluorescein (FAM) as the 59-reporter and 39
TAMRA quencher (Applied Biosystems, Foster City, CA). The
commercially available Taqman Gene Expression Assays (Applied
Biosystems, Foster City, CA): IL2 (Ss03392429_m1), CD28
(Ss03373720_s1), CTLA-4 (Ss03394185_m1) were used in the
present study. Each system was re-evaluated and optimized for the
current approach, and all reagents were titrated for optimal
performance using total RNA isolated from porcine PBMCs that
were induced to produce the various cytokines and receptors
according to established protocols. Five-fold serial dilutions
(triplicate) of total RNA extracted from PBMCs were amplified
by real-time RT-PCR using gene-specific primers to calculate the
amplification efficiency of each system and a non-template control
of nuclease-free water was included in each run.
The cycle threshold (Ct) value was determined for each sample.
To evaluate the relative quantification of mRNA expression, the
Ct-values of the target genes were normalized to the Ct-values of
the housekeeping gene HPRT and the results were presented as
fold change using the 2
2DDCt method.
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Concentrations of TNF-a and IFN-c in cell culture supernatants
were determined by means of commercially available ELISA kits
(R&D Systems, Minneapolis, MN). The dynamic range of the TNF-a
assay was 23.4 to 1500 pg/ml. The minimum detectable dose was
3.7 pg/ml. The intra-assay coefficient of variation was ,4.2% and
the inter-assay coefficient of variation was ,6.5%. The dynamic
range of the IFN-c assay was 2.7 to 11.2 pg/ml. The mean minimum
detectable dose was 6.1 pg/ml. The intra-assay coefficient of variation
was ,2.9% and the inter-assay coefficient of variation was ,9.4%.
Western blot
PBMCs were harvested and lysed in lysis buffer containing
150 mM NaCl, 10 mM Tris-HCl (pH 7.9), 0.5% Triton X-100,
0.6% NP-40, supplemented with protease inhibitors (1 mg/ml
leupeptin, 1 mg/ml pepstatin A, and 2 mg/ml aprotinin). Lysates
were frozen at 280uC, thawed, and centrifuged to remove the
insoluble pellet. The protein concentration in the supernatant was
determined by a protein assay (Bio-Rad Laboratories, Hercules, CA).
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer (10 mM Tris-HCl, pH 6.8, 2% SDS, 10%
glycerol, 0.2 M DTT) was added to the lysates. Lysates were heated
to 100uCfo r5m i n ,a n d8 0mg of protein was loaded into each well of
a 10% SDS-PAGE gel. Resolved proteins were electrophoretically
transferred to nitrocellulose and blocked with 5% non-fat milk, and
the primary antibody human CTLA-4 affinity purified polyclonal
antibody (dilution 1:500). After overnight incubation at 4uCt h eb l o t s
were washed, exposed to secondary antibody rabbit anti-goat IgG
HRP (horseradish peroxidase) (R&D Systems, Minneapolis, MN)
(dilution 1:1000) for 1 h, and finally detected by ECL. The GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) in each sample was
amplified as an internal control as shown in the lower panel.
Statistical analysis
All statistical evaluations were conducted by use of the SPSS
statistical software, Version 16.0 (SPSS Inc.,Chicago, IL). The
data were compared using the parametric test one-way analysis of
variance (ANOVA) and differences were tested by non-parametric
Dunnett’s test. P-values ,0.05 were considered statistically
significant. The data were presented as means 6 SEM.
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